Thomas Gossios retweeted
VExUS score for the assessment of multi-organ venous congestion in acute heart failure, predicts in-hospital mortality. #jase #echofirst @VDelgadoGarcia @T_Karamitsos @manthosdid @GossiosThomas @ASE360 @echotalk @EchofirstB @EACVIPresident @AuthMedicine @Auth_University
Thomas Gossios retweeted
#Amyloidosis #CardioTwitter
A rare, but fascinating and relevant finding, that ATTR-CM–ass. HF can resolve spontaneously, with reversion to near-normal🫀structure and function!
There might be a possibility of antiamyloid immune response: polyclonal IgG AB to human ATTR ➡️bound specifically to ATTR deposits. bit.ly/47loDgA
Thomas Gossios retweeted
We are looking for a senior fellow in Inherited Cardiomyopathies at St. Bartholomew’s Hospital. Exciting opportunity for training in ICVD and imaging and research. Applications at:
jobs.nhs.uk/candidate/jobadv…
Thomas Gossios retweeted
Having a child is one of the most profound things you will do in your life.
I had my first child later in life ~ 40.
Here are 5 things that having a child has taught me.
Thomas Gossios retweeted
Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy @JACCJournals - using new indexed thresholds. So glad to contribute to redefining hypertrophic cardiomyopathy for more accurate diagnoses. congrats to @DrRebeccaHughes for another amazing paper on apical HCM
A wall thickness of 15mm reflects far greater hypertrophy at the apex than the base. Apical HCM can be reliably diagnosed with an indexed wall thickness less than you’d expect.
Read more here ⬇️
jacc.org/doi/10.1016/j.jcmg.…
@JccmoonMoon @HunainShiwani @gabycaptur @UCL_ICS
Thomas Gossios retweeted
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants
@Circ_Gen
ahajournals.org/doi/10.1161/…
Thomas Gossios retweeted
Our paper on "Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies" is published today in @NatureCVR nature.com/articles/s44161-0… A brief thread on the main findings in the study:
Thomas Gossios retweeted
RV-PA uncoupling assessed by TAPSE/PASP ratio <0.36mm/mmHg is associated with increased mortality in HF patients: data from our meta-analysis @T_Karamitsos @GossiosThomas #Cardiotwitter #Echofirst #HeartFailure #AUTh #Cardiology link.springer.com/article/10…
Thomas Gossios retweeted
(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented @escardio #ESCCongress. We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...
Thomas Gossios retweeted
Well done to @dougcannie and the consortium for this excellent work that will help with risk stratification of individuals with EDMD1!
Published today at the EHJ! @ESC_Journals
academic.oup.com/eurheartj/a…
Thomas Gossios retweeted
A dobutamine stress echo remains a widely used method for detection of CAD in patients with ESLD despite low sensitivity.
Speckle-tracking assessment of strain may enhance the sensitivity of DSE, but the value of strain analysis in ESLD is unknown. bit.ly/45dOnug
Thomas Gossios retweeted
#DidYouKnow we have an entire Microlesson Series on HCM, comprised of 13 videos (and counting) that dive into all things #HCM?
View them all on our YouTube channel: bit.ly/3OCOsCv
Thomas Gossios retweeted
my PhD study now out in @CircAHA! Detection of micro-structural/vascular abnormalities in subclinical & overt HCM using DTI/quantitative perfusion #WhyCMR 🧲🔬
Thank you to my supervisors @EArmellina @jccmoonmoon @LuisRLopesDr
doi.org/10.1161/CIRCULATIONA…
Thomas Gossios retweeted
I’d just like to apologise to everyone for my abject failure
This was spotted in a local radiology registrar report today
Again, sorry. I promise to do better as a trainer. I will redouble my efforts. This Never Event won’t happen again
Thomas Gossios retweeted
Lifetime Clinical Course of HCM over 50 years:
- HCM mortality 2x in 2nd-3rd decade from diagnosis
- Driven by HF (1.4%/y), SCD is low (0.4%/y)
- Contemporary treatment strategies may decrease mortality by 40%
@JACCJournals @IacopoOlivotto @MartinMaronMD
jacc.org/doi/epdf/10.1016/j.…
Thomas Gossios retweeted
Today we presented the full results of #REDWOOD #HCM #Cohort4 #HFA2023 @escardio , this is a p2 trial of #aficamten in #nHCM
Here are the results, and based on them our patients will get to consider participation in a phase III trial later this year -stay tuned
#CardioTwitter
Thomas Gossios retweeted
LIVE-HCM: Individuals with hypertrophic cardiomyopathy exercising vigorously or competitively do not have a heightened risk of death or arrhythmic events compared to those exercising moderately or those who were sedentary. ja.ma/42Li1Go
Thomas Gossios retweeted
What is the incidence of stroke in HCM in stable sinus rhythm?
-2.3%/year
-LAD>48mm>>10x risk of stroke
-should we study #atrialdisease #LAStrain in #HCM?
#CardioEd #Cardiology #CardioTwitter @IacopoOlivotto @MauriziNiccolo @mauripieroni72 @IoannisSkalidis doi.org/10.1016/j.ijcard.202…
Thomas Gossios retweeted
There is no rope in this image. This is carved from a single block of marble.
Is there a person alive today who could do this?








































